Mundipharma and CorMedix have unveiled a win for their antifungal drug Rezzayo at preventing invasive fungal diseases in ...

In the trial, aimed at evaluating the safety and efficacy of once-weekly Rezzayo, the drug demonstrated a profile comparable with standard antimicrobial regimen in reducing the incidence of invasive ...

Serious fungal infections are on the rise, and many hospital-acquired cases are becoming harder to treat as fungi become ...

Fungal infections caused by Candida species pose a growing threat to global health, particularly in immunocompromised and critically ill patients. The rise ...

Patients taking Tibsovo to treat MDS or AML may want to discuss the appropriate medications to treat and prevent infections, an expert said. Tibsovo (ivosidenib), which is used to treat patients with ...

An increasing number of fungi are becoming resistant to medication, posing serious risks for patients with weakened immune ...

The city's health department is advising providers to increase screening for C. auris, which can lead to life-threatening ...

Invasive fungal infections are now estimated to affect about 6.5 million people every year around the world, and while many ...

Fungal infections, from athlete’s foot to life-threatening bloodstream diseases, are becoming harder to treat as drug resistance spreads. Doctors are turning to new medications, innovative therapies, ...